Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Folkert J. van Kemenade

Erasmus University Rotterdam

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Biostatistics

40%

Epidemiology

60%

Thyroid Cancer

50%

Cancer Biology

40%

Cervical Cancer

40%

Oncology

40%

Prognostic Biomarker

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles28

Risk of colorectal cancer and participation in fecal immunochemical test-based screening

Article Link

Year:

2025

The impact of extended invitation intervals on stage distribution of screen-detected and interval cancer within the Dutch colorectal cancer screening program

Article Link

Year:

2025

The effect of bivalent HPV vaccination against invasive cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3+) in the Netherlands

Article Link

Year:

2025

Radioactive Iodine in Differentiated Thyroid Cancer: Effect on Detection of Distant Metastases Comparing 4 Guidelines

Article Link

Year:

2025

Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations

Article Link

Year:

2025

Opt-In versus opt-out for the secondary use of routinely recorded health data

Article Link

Year:

2025

Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer

Article Link

Year:

2025

The impact of loss to follow‐up in the Dutch organised HPV‐based cervical cancer screening programme

Article Link

Year:

2024

Incidental findings in NIPT show potential for detecting hematological malignancies

Article Link

Year:

2024

Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification

Article Link

Year:

2024

Perspective of obstetric care-providers on being involved in cervical cancer screening during antenatal care in the Netherlands

Article Link

Year:

2024

Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue

Article Link

Year:

2024

Predictors of treatment response in lymphogenic metastasized papillary thyroid cancer

Article Link

Year:

2024

COVID-19 in the Netherlands

Article Link

Year:

2024

Clinical and Histopathological Risk Factors for Radioactive Iodine–Refractory Follicular and Oncocytic Thyroid Carcinoma

Article Link

Year:

2024

Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic

Article Link

Year:

2024

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

Article Link

Year:

2024

Interval cancer risk after the upper age limit of screening has been reached

Article Link

Year:

2024

The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia

Article Link

Year:

2023

Quantitative Proteomic Analysis of MCM3 in ThinPrep Samples of Patients with Cervical Preinvasive Cancer

Article Link

Year:

2023

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

Article Link

Year:

2023

European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules

Article Link

Year:

2023

Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme

Article Link

Year:

2023

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening

Article Link

Year:

2023

The Role of the IGF2 Methylation Score in Diagnosing Adrenocortical Tumors with Unclear Malignant Potential—Feasibility of Formalin-Fixed Paraffin-Embedded Tissue

Article Link

Year:

2023

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme

Article Link

Year:

2023

Tumor size and presence of metastases in differentiated thyroid cancer

Article Link

Year:

2023

Evaluating Disease Specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer

Article Link

Year:

2023

Collaborators15

Nanda Horeweg

Assistant Professor

Leiden University Medical Center

NETHERLANDS

Frank Hoentjen

Associate professor

University of Alberta

CANADA

Harm Haak

Maastricht University Medical Centre

NETHERLANDS

Heleen J van Beekhuizen

Erasmus University Rotterdam

NETHERLANDS

Helena C van Doorn

university medical center rotterdam

NETHERLANDS

Leo Hofland

Erasmus University Rotterdam

NETHERLANDS

Ruud Bekkers

professor in gynecologic oncology

University of Maastricht

NETHERLANDS

I. M. C. M. de Kok

NETHERLANDS

Caroline Muntinga

University of Maastricht

NETHERLANDS

Lucie de Jonge

Erasmus University Rotterdam

NETHERLANDS

Nicole Erler

Erasmus University Rotterdam

NETHERLANDS

Iris Lansdorp-Vogelaar

Associate Professor

Erasmus University Medical Center

NETHERLANDS

Evelien Dekker

Professor

Amsterdam University Medical Centers

NETHERLANDS

Manon C W Spaander

NETHERLANDS

Ralf van de Laar

Erasmus University Rotterdam

NETHERLANDS

How do I reach out?

Meet Kite AI